Actual Medicinal Product (AMP) - COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.)

Navigation

Name Details

Name Start Date End Date
Name Current Name COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials Start Date 23-02-2022 End Date
Previous Name Previous Name COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials Start Date 16-03-2021 End Date 22-02-2022
Abbreviated Name Abbreviated Name COVID-19 Vaccine Nuvaxovid 0.5ml inj multidose vials Start Date 23-02-2022
Previous Abbreviated Name COVID-19 Vaccine Novavax 0.5ml inj multidose vials Previous Start Date 30-11-2021 Previous End Date 22-02-2022

Summary

Licensed Route
Intramuscular
Availability Restrictions
Restricted Availability
Licensing Authority
Medicines - MHRA/EMA
EMA Indicator
EMA Monitoring

Codes

BNF Start Date End Date
Previous BNF 14040000 Start Date 16-03-2021 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39473011000001103 16-03-2021

Parent Products

Actual Medicinal Product Pack (AMPP) Information

Pack Size Indicative Price Discontinued
10 dose
100 dose